SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-22-001710
Filing Date
2022-02-15
Accepted
2022-02-15 17:18:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G mossei_sc13g.htm SC 13G 36442
  Complete submission text file 0001654954-22-001710.txt   37652
Mailing Address 27 RIPPLEVALE GROVE LONDON X0 N1 1HS
Business Address
Mosseri Marlio Charles (Filed by) CIK: 0001806384 (see all company filings)

Type: SC 13G

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93555 | Film No.: 22640220
SIC: 2834 Pharmaceutical Preparations